Who
Timothy J. Bettington
Officer
Company insider
Files Form 4 as: Officer, Elanco Animal Health; Executive Vice President, Zoetis.
In numbers
- Trades disclosed
- 38
- Buys
- 0
- Sells
- 1
- Bought
- $0
- Sold
- $100K
- Companies
- 2
- Companies where not an officer
- 0
- First trade
- 11 Feb 2020
- Last trade
- 15 Oct 2026
- Last filed
- 19 Oct 2026
Companies traded
Activity over time
Not enough dated trades to draw.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 15 Oct 2026filed 19 Oct 2026 | ELAN Elanco Animal HealthPharmaceuticals | SEC FORM 4 Sold | $100K4,350 at $23.00 | filing |
| 3 Mar 2026filed 5 Mar 2026 | ELAN Elanco Animal HealthPharmaceuticals | SEC FORM 4 Code F | $117K4,695 at $24.88 | filing |
| 3 Mar 2026filed 5 Mar 2026 | ELAN Elanco Animal HealthPharmaceuticals | SEC FORM 4 Code F | $117K4,695 at $24.88 | filing |
| 1 Mar 2026filed 3 Mar 2026 | ELAN Elanco Animal HealthPharmaceuticals | SEC FORM 4 Code A | —46,322 at $0.00 | filing |
| 1 Mar 2026filed 3 Mar 2026 | ELAN Elanco Animal HealthPharmaceuticals | SEC FORM 4 Code F | $478K18,098 at $26.40 | filing |
| 1 Mar 2026filed 3 Mar 2026 | ELAN Elanco Animal HealthPharmaceuticals | SEC FORM 4 Code A | —9,470 at $0.00 | filing |
| 1 Mar 2026filed 3 Mar 2026 | ELAN Elanco Animal Healthoption or derivative · Pharmaceuticals | SEC FORM 4 Code A | —19,350 at $0.00 | filing |
| 1 Mar 2026filed 3 Mar 2026 | ELAN Elanco Animal Healthoption or derivative · Pharmaceuticals | SEC FORM 4 Code A | —19,350 at $0.00 | filing |
| 1 Mar 2026filed 3 Mar 2026 | ELAN Elanco Animal HealthPharmaceuticals | SEC FORM 4 Code A | —46,322 at $0.00 | filing |
| 1 Mar 2026filed 3 Mar 2026 | ELAN Elanco Animal HealthPharmaceuticals | SEC FORM 4 Code F | $478K18,098 at $26.40 | filing |
| 1 Mar 2026filed 3 Mar 2026 | ELAN Elanco Animal HealthPharmaceuticals | SEC FORM 4 Code A | —9,470 at $0.00 | filing |
| 3 Apr 2025filed 7 Apr 2025 | ELAN Elanco Animal HealthPharmaceuticals | SEC FORM 4 Code F | $229K23,558 at $9.72 | filing |
| 3 Mar 2025filed 5 Mar 2025 | ELAN Elanco Animal Healthoption or derivative · Pharmaceuticals | SEC FORM 4 Code A | —64,936 at $0.00 | filing |
| 3 Mar 2025filed 5 Mar 2025 | ELAN Elanco Animal HealthPharmaceuticals | SEC FORM 4 Code A | —30,947 at $0.00 | filing |
| 1 Mar 2025filed 4 Mar 2025 | ELAN Elanco Animal HealthPharmaceuticals | SEC FORM 4 Code F | $39K3,514 at $11.17 | filing |
| 3 Apr 2024filed 5 Apr 2024 | ELAN Elanco Animal HealthPharmaceuticals | SEC FORM 4 Code F | $363K23,557 at $15.43 | filing |
| 1 Mar 2024filed 5 Mar 2024 | ELAN Elanco Animal Healthoption or derivative · Pharmaceuticals | SEC FORM 4 Code A | —47,620 at $0.00 | filing |
| 1 Mar 2024filed 5 Mar 2024 | ELAN Elanco Animal HealthPharmaceuticals | SEC FORM 4 Code A | —21,835 at $0.00 | filing |
| 3 Apr 2023filed 5 Apr 2023 | ELAN Elanco Animal HealthPharmaceuticals | SEC FORM 4 Code A | —108,109 at $0.00 | filing |
| 7 Oct 2022filed 11 Oct 2022 | ZTS Zoetisoption or derivative · Pharmaceuticals | SEC FORM 4 Code A | $8,212175.61 at $46.76 | filing |
News
No headline names them, or the companies they trade most, lately.